| abstract |
The present invention provides a compound of formula (I), a prodrug thereof, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a prodrug thereof. More specifically, the present invention provides high affinity nonsteroidal compounds that are agonists, partial agonists or antagonists of progesterone receptors.n n n Formula I |